These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 34174249)

  • 21. Genotypic analysis of cytomegalovirus retinitis poorly responsive to intravenous ganciclovir but responsive to the ganciclovir implant.
    Kuo IC; Imai Y; Shum C; Martin DF; Kuppermann BD; Margolis TP
    Am J Ophthalmol; 2003 Jan; 135(1):20-5. PubMed ID: 12504692
    [TBL] [Abstract][Full Text] [Related]  

  • 22. High-dose Valganciclovir Treatment for Resistant Cytomegalovirus Colitis due to UL97 and UL54 Mutations.
    Baradhi KM; Aure RL; El-Amm JM
    Transplant Proc; 2018; 50(1):142-144. PubMed ID: 29407298
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Development of new cytomegalovirus UL97 and DNA polymerase mutations conferring drug resistance after valganciclovir therapy in allogeneic stem cell recipients.
    Marfori JE; Exner MM; Marousek GI; Chou S; Drew WL
    J Clin Virol; 2007 Feb; 38(2):120-5. PubMed ID: 17157554
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Lack of resistance-associated mutations in UL54 and UL97 genes of circulating cytomegalovirus strains isolated in a medical center in Taiwan.
    Shao PL; Lu MY; Liau YJ; Kao CL; Chang SY; Huang LM
    J Formos Med Assoc; 2012 Aug; 111(8):456-60. PubMed ID: 22939665
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Molecular Analysis of Ganciclovir-Resistant Cytomegalovirus in Renal Transplant Recipients with High Viral Load.
    Sohrabi M; Behzadian F; Hosseini SM; Lashini H
    Arch Iran Med; 2016 Oct; 19(10):700-703. PubMed ID: 27743434
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Epidemiology of cytomegalovirus antiviral resistance testing for solid organ and bone marrow transplant patients from 2011 - 2019.
    Li L; Lowe CF; McLachlan E; Romney MG; Wright A; Matic N
    J Clin Virol; 2023 Sep; 166():105549. PubMed ID: 37478805
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The impact of drug-resistant cytomegalovirus in pediatric allogeneic hematopoietic cell transplant recipients: a prospective monitoring of UL97 and UL54 gene mutations.
    Choi SH; Hwang JY; Park KS; Kim Y; Lee SH; Yoo KH; Kang ES; Ahn JH; Sung KW; Koo HH; Kim YJ
    Transpl Infect Dis; 2014 Dec; 16(6):919-29. PubMed ID: 25405808
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The biology of cytomegalovirus drug resistance.
    Hakki M; Chou S
    Curr Opin Infect Dis; 2011 Dec; 24(6):605-11. PubMed ID: 22001948
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Characterization of the dynamics of human cytomegalovirus resistance to antiviral drugs by ultra-deep sequencing.
    Guermouche H; Burrel S; Mercier-Darty M; Kofman T; Rogier O; Pawlotsky JM; Boutolleau D; Rodriguez C
    Antiviral Res; 2020 Jan; 173():104647. PubMed ID: 31706899
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Antiviral susceptibilities and analysis of UL97 and DNA polymerase sequences of clinical cytomegalovirus isolates from immunocompromised patients.
    Erice A; Gil-Roda C; Pérez JL; Balfour HH; Sannerud KJ; Hanson MN; Boivin G; Chou S
    J Infect Dis; 1997 May; 175(5):1087-92. PubMed ID: 9129070
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cytomegalovirus resistance in solid organ transplant recipients treated with intravenous ganciclovir or oral valganciclovir.
    Boivin G; Goyette N; Rollag H; Jardine AG; Pescovitz MD; Asberg A; Ives J; Hartmann A; Humar A
    Antivir Ther; 2009; 14(5):697-704. PubMed ID: 19704173
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Improvement in detecting cytomegalovirus drug resistance mutations in solid organ transplant recipients with suspected resistance using next generation sequencing.
    López-Aladid R; Guiu A; Mosquera MM; López-Medrano F; Cofán F; Linares L; Torre-Cisneros J; Vidal E; Moreno A; Aguado JM; Cordero E; Martin-Gandul C; Carratalá J; Sabé N; Niubó J; Cervera C; Capón A; Cervilla A; Santos M; Bodro M; Muñoz P; Fariñas MC; Antón A; Aranzamendi M; Montejo M; Pérez-Romero P; Len O; Marcos MÁ
    PLoS One; 2019; 14(7):e0219701. PubMed ID: 31318908
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Accelerated evolution of maribavir resistance in a cytomegalovirus exonuclease domain II mutant.
    Chou S; Marousek GI
    J Virol; 2008 Jan; 82(1):246-53. PubMed ID: 17942550
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Sequence analysis of UL54 and UL97 genes and evaluation of antiviral susceptibility of human cytomegalovirus isolates obtained from kidney allograft recipients before and after treatment.
    Mousavi-Jazi M; Hökeberg I; Schloss L; Zweygberg-Wirgart B; Grillner L; Linde A; Brytting M
    Transpl Infect Dis; 2001 Dec; 3(4):195-202. PubMed ID: 11844151
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cytomegalovirus antiviral resistance: characterization of results from clinical specimens.
    Kleiboeker S; Nutt J; Schindel B; Dannehl J; Hester J
    Transpl Infect Dis; 2014 Aug; 16(4):561-7. PubMed ID: 24903568
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Antiviral drug resistance in human cytomegalovirus.
    Chou S
    Transpl Infect Dis; 1999 Jun; 1(2):105-14. PubMed ID: 11428978
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Valganciclovir as pre-emptive therapy for cytomegalovirus infection post-allogenic stem cell transplantation: implications for the emergence of drug-resistant cytomegalovirus.
    Allice T; Busca A; Locatelli F; Falda M; Pittaluga F; Ghisetti V
    J Antimicrob Chemother; 2009 Mar; 63(3):600-8. PubMed ID: 19147520
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Quantitative changes in cytomegalovirus DNAemia and genetic analysis of the UL97 and UL54 genes in AIDS patients receiving cidofovir following ganciclovir therapy.
    Bowen EF; Cherrington JM; Lamy PD; Griffiths PD; Johnson MA; Emery VC
    J Med Virol; 1999 Aug; 58(4):402-7. PubMed ID: 10421408
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Analysis of cytomegalovirus DNA polymerase (UL54) mutations in solid organ transplant patients receiving valganciclovir or ganciclovir prophylaxis.
    Boivin G; Goyette N; Gilbert C; Covington E
    J Med Virol; 2005 Nov; 77(3):425-9. PubMed ID: 16173018
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Generation and characterization of a GCV resistant HCMV UL97-mutation and a drug sensitive UL54-mutation.
    Fischer L; Laib Sampaio K; Jahn G; Hamprecht K; Göhring K
    Antiviral Res; 2013 Dec; 100(3):575-7. PubMed ID: 24120366
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.